Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.70 |
| ▸ | MTOR | P42345 | 2/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.70 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.70 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | HBB | P68871 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.49 |
| ▸ | SLC28A1 | O00337 | 2/20 | 0.49 |
| ▸ | SLC28A2 | O43868 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16946221 | 1.00 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL16941689 | 1.00 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL20953418 | 1.00 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL30664789 | 0.99 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL288517 | 0.99 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL6302404 | 0.99 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL42103 | 0.99 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| Water SCHEMBL6475042 | 0.97 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| Water SCHEMBL6475036 | 0.97 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL21418700 | 0.87 | LMNA (0.57) | LMNAMTORTHRBMDM2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10273313-B2 | Multimeric mannosides, a process for preparing the same and their uses as a drug | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10273313-B2 | Multimeric mannosides, a process for preparing the same and their uses as a drug | MANBA, MAN2A1, MAN2B2 | LMNA 1947/4885MTOR 2959/4885THRB 4791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.